Karen Kochevar - Aug 27, 2024 Form 4 Insider Report for CAVA GROUP, INC. (CAVA)

Role
Director
Signature
/s/ Kenneth Robert Bertram, as Attorney-in-Fact
Stock symbol
CAVA
Transactions as of
Aug 27, 2024
Transactions value $
-$2,329,000
Form type
4
Date filed
8/29/2024, 04:06 PM
Previous filing
Jun 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAVA Common Stock Options Exercise $38.4K +20K +1530.22% $1.92 21.3K Aug 27, 2024 Direct F1
transaction CAVA Common Stock Sale -$1.19M -10K -46.93% $118.58 11.3K Aug 27, 2024 Direct F1, F2
transaction CAVA Common Stock Sale -$1.18M -10K -88.44% $118.16 1.31K Aug 27, 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAVA Stock Options (right to buy) Options Exercise $0 -20K -29.46% $0.00 47.9K Aug 27, 2024 Common Stock 20K $1.92 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes unvested restricted stock units.
F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.54 to $118.73, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
F3 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.13 to $118.33, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
F4 All of the shares subject to this option are fully vested and exercisable as of the date hereof.